Arenavirus glycoprotein-host cell receptor interactions
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Pichinde virus (PICV) is an enveloped single-stranded RNA New World
arenavirus. The new world arenaviruses are divided into three separate
clades designated as A, B, and C. The clade B arenaviruses are known to
cause severe viral hemorrhagic fever. The clade A PICV is prevalent in the
rodent population of Colombia. PICV is currently designated as a biosafety
level-2 (BSL 2) pathogen due to its low pathogenicity in humans. Efforts
have been made to identify the cellular receptors utilized by the virus
glycoproteins to enter the host cell. Clade B arenaviruses utilize various
species-specific forms of Transferrin Receptor 1 to gain access to the inside
of a host cell where they replicate. The cellular receptor that mediates
entry by clade
A
arenaviruses
has
not
been
identified
and
is
the
basis
of
my
OBJECTIVE
research. The goal of this study is to purify PICV glycoprotein variants
containing multiple truncations in order to study the binding of the
glycoprotein to cells from highly susceptible host species. We have
designed and purified multiple protein truncations of the PICV virus
glycoprotein. The binding interactions of these protein truncations requires
further study.
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• PICV is prevalent in the rodent populations of the northeast region of
South America.

•

• The cell surface protein receptor for the PICV virus has yet to be
identified.

•

• New World arenaviruses have been separated into 3 distinct clades: A,
B, & C. PICV is a clade A arenavirus.

•

Cells. Human Embryonic Kidney 293 cells (HEK-293) were
purchased from American Type Culture Collection (ATCC) and
grown in DMEM media.
Plasmid. Multiple plasmids were constructed to express
different truncations of the PICV glycoprotien. The PICV
plasmids contain the human Fc region which allows for
purification with affinity chromatography.
Plasmids were amplified using MC1061 E. coli cells, and
purified using a Qiagen Maxi Kit (cat. #12162).
HEK-293 cells were grown in T150 flask at 37 ⁰C and 5% CO2 in
DMEM media with 10% FBS at a density of 1.6x107 cells/flask.
At 18 hours post seeding the cells were transfected with 80
μg of an expression plasmid coding for the PICV viral
glycoprotein.
The cells were transfected with the plasmids via the calcium
phosphate method.
After a 6 hour incubation period, the cells were washed using
warm PBS and SFMII media that contained 1x L-glutamine,
non-essential amino acids, amino acids, and sodium butyrate.
Protein A – Sepharose 4B beads (Invitrogen, cat. #101041) were
used to bind to the Fc region of the plasmid for affinity
chromatography.
After purification, dialysis was performed overnight at 4 ⁰C in
1X PBS.
Once the protein was purified it was concentrated using a 50
kDa centrifugal filter (Amicon, cat. #UFC505024).
Protein concentration was determined by performing a
Bradford Assay.
Protein identification was performed using an SDS-Page gel to
verify the size and purity of the protein sample.

PICV plasmids were amplified
using MC1061 E. coli cells and
purified using the Qiagen Maxi Kit.

HEK293 cells were cultured
in T150 flasks.

Transfection via calcium
phosphate method.

Plasmid verification via gel
electrophoresis.
HEK293 cells were transfected
with the PICV plasmid or the
GFP plasmid via calcium
phosphate. The GFP was used
to determine the transfection
efficiency of the procedure by
fluorescent microscopy.

• Arenaviruses are negative sense single strand RNA enveloped viruses
• PICV is less pathogenic than other arenaviruses such as the Junin, Clade
B, arenavirus.
• This study is modeled after former studies used in identifying the
protein receptor for the Clade B Machupo arenavirus. 1
• Due to its non-pathogenicity in humans, PICV is commonly used to
evaluate treatments for arenaviral hemorrhagic fever.

Results

B.

Bradford Assay

Secreted proteins were collected from the
supernatant and purified using Protein A Sepharose 4B beads. The eluted solution
was then diluted using dialysis cassettes

• The PICV glycoprotein exists as a trimer.

(Thermo Scientific, cat. #66453).

(Adapted from: www.cellmosaic.com)

Discussion

Engineered
Pichinde
virus2
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Estimated protein concentration was 14.7 μg/ml.
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Dialysis was performed in 1x PBS
buffer at 4° C overnight.

Transfect and amplify various truncations of the PICV viral glycoprotein in
HEK293 cells.
Extract glycoprotein and determine concentration via a Bradford Assay.
Purify protein using affinity chromatography. Measure the binding affinity of
the PICV glycoprotein to baby hamster kidney cells (BHK) surface receptors.
Attempt to identify the cell surface protein receptor for PICV.
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SDS Page gel electrophoresis
The reduced but nondenatured sample was
estimated to be~150 kDa
(compared to the protein
standards ladder, far left
lane).

The reduced and
denatured sample was
estimated to be ~85 kDa.

The concentration of 14.7 μg/ml was within the range of the expected
yield.
The PICV glycoprotein and the denatured band is larger than calculated,
likely due to glycosylation by the HEK293 cells.
The next step is to study the binding affinities of the purified PICV
glycoproteins with the baby hamster kidney (BHK) cell surface receptors.
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Conclusion
• The protein amplification and purification protocol proved to be a successful
and effective method.
• Due to time restrictions, the binding affinity assays have yet to be performed.
• Once the affinity assays are completed additional studies will be conducted to
identify the specific cell surface receptor utilized by PICV.

